FDA 483 - Terumo Cardiovascular Systems Corporation - December 16, 2022

Terumo Cardiovascular Systems Corporation in Elkton, MD, a medical device manufacturer, received a Form FDA 483 with two significant observations. The inspection revealed inadequate procedures for preventing product contamination, evidenced by numerous foreign matter incidents, and deficiencies in their customer complaint handling process. These issues indicate a need for improved quality system controls.